SEC Form 4 reporting owner

Bigora Sian

Bigora Sian has filed 4 Form 4 transactions reported between January 1, 2026 and April 30, 2026, as Chief Development Officer of Processa Pharmaceuticals, Inc..

Name as filed: Bigora Sian

Open-market buys, 24 mo
$16K
3 lines
Open-market sales, 24 mo
None
reported
Companies
1
with Form 4 filings
Latest transaction
Apr 30, 2026
transaction date

Roles and reported holdings

  • PCSAProcessa Pharmaceuticals, Inc.
    Jan 1, 2026 – Apr 30, 2026

    Chief Development Officer

    Held directly7,496 sh as of Apr 30, 2026 · Form 4

    24 months: $16K bought

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Apr 30, 2026PCSAChief Development OfficerOpen-market purchaseCode P · direct1,986$5K@ $2.69Form 4
Apr 15, 2026PCSAChief Development OfficerOpen-market purchaseCode P · direct1,799$5K@ $2.97Form 4
Mar 31, 2026PCSAChief Development OfficerOpen-market purchaseCode P · direct2,107$5K@ $2.54Form 4
Jan 1, 2026PCSAChief Development OfficerOption exerciseCode M · direct249—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.